Yoshioka A - Search Results

1

Pathophysiology of oligodendroglial excitotoxicity.

Yoshioka A, Bacskai B, Pleasure D. Yoshioka A, et al. J Neurosci Res. 1996 Nov 15;46(4):427-37. doi: 10.1002/(SICI)1097-4547(19961115)46:4<427::AID-JNR4>3.0.CO;2-I. J Neurosci Res. 1996. PMID: 8950702

2

Non-N-methyl-D-aspartate glutamate receptors mediate oxygen--glucose deprivation-induced oligodendroglial injury.

Yoshioka A, Yamaya Y, Saiki S, Kanemoto M, Hirose G, Beesley J, Pleasure D. Yoshioka A, et al. Brain Res. 2000 Jan 31;854(1-2):207-15. doi: 10.1016/s0006-8993(99)02359-8. Brain Res. 2000. PMID: 10784123

3

Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line.

Yoshioka A, Yamaya Y, Saiki S, Kanemoto M, Hirose G, Pleasure D. Yoshioka A, et al. J Neurochem. 2000 Feb;74(2):633-40. doi: 10.1046/j.1471-4159.2000.740633.x. J Neurochem. 2000. PMID: 10646514

4

[Ibudilast prevents oxygen-glucose deprivation-induced oligodendroglial injury].

Yoshioka A, Yamaya Y, Hirose G. Yoshioka A, et al. No To Shinkei. 1999 Jan;51(1):49-54. No To Shinkei. 1999. PMID: 10065460 Japanese.

5

[Ibudilast prevents oligodendroglial excitotoxicity].

Yoshioka A, Shimizu Y, Hirose G. Yoshioka A, et al. No To Shinkei. 1997 Nov;49(11):1015-20. No To Shinkei. 1997. PMID: 9396033 Japanese.

6

Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity.

Yoshioka A, Shimizu Y, Hirose G, Kitasato H, Pleasure D. Yoshioka A, et al. J Neurochem. 1998 Jun;70(6):2416-23. doi: 10.1046/j.1471-4159.1998.70062416.x. J Neurochem. 1998. PMID: 9603206

7

Type-2 astrocyte-like cells are more resistant than oligodendrocyte-like cells against non-N-methyl-D-aspartate glutamate receptor-mediated excitotoxicity.

Yamaya Y, Yoshioka A, Saiki S, Yuki N, Hirose G, Pleasure D. Yamaya Y, et al. Among authors: yoshioka a. J Neurosci Res. 2002 Nov 15;70(4):588-98. doi: 10.1002/jnr.10425. J Neurosci Res. 2002. PMID: 12404513

8

Expression of glutamic acid decarboxylase during human neuronal differentiation: studies using the NTera-2 culture system.

Yoshioka A, Yudkoff M, Pleasure D. Yoshioka A, et al. Brain Res. 1997 Sep 5;767(2):333-9. doi: 10.1016/s0006-8993(97)00627-6. Brain Res. 1997. PMID: 9367265

9

Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cells lines.

Yoshioka A, Ikegaki N, Williams M, Pleasure D. Yoshioka A, et al. J Neurosci Res. 1996 Oct 15;46(2):164-78. doi: 10.1002/(SICI)1097-4547(19961015)46:2<164::AID-JNR4>3.0.CO;2-F. J Neurosci Res. 1996. PMID: 8915893

CG-4 expressed mRNAs encoding GluR2-7, KA-1, and KA-2 non-NMDA GluR (Yoshioka et al.: J Neurochem 64:2442-2448, 1995) and NR1 (NMDAR1) and NR2D NMDA GluR. ...Whereas CG-4 is susceptible to kainate excitotoxicity, treatment of insulinoma, neuroblastoma, and medulloblastoma …

CG-4 expressed mRNAs encoding GluR2-7, KA-1, and KA-2 non-NMDA GluR (Yoshioka et al.: J Neurochem 64:2442-2448, 1995) and NR1 (NMDAR1 …

10

cDNA cloning, molecular characterization, and chromosomal localization of NET(EPHT2), a human EPH-related receptor protein-tyrosine kinase gene preferentially expressed in brain.

Tang XX, Biegel JA, Nycum LM, Yoshioka A, Brodeur GM, Pleasure DE, Ikegaki N. Tang XX, et al. Among authors: yoshioka a. Genomics. 1995 Sep 20;29(2):426-37. doi: 10.1006/geno.1995.9985. Genomics. 1995. PMID: 8666391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results